Wei-Chen Lin

7PUBLICATIONS
18CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Other Asian languages (excl. South-East Asian)Nutritional epidemiologyDisease surveillanceMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 31, 2026
Real-World Patterns of Immunomodulator Use in Patients with Inflammatory Bowel Disease Receiving Biologic Therapy Under a 54-Week Reimbursement Cap: A 12-Year Retrospective Single-Center Cohort from Taiwan.

|Jun 05, 2026
Distinct predictive factors for acute severe ulcerative colitis in East Asian and Western populations.

|Jul 12, 2023
Discontinuation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn's Disease: Individual Participant Data Meta-Analysis of 309 Patients from 12 Studies.

Sebastiaan Ten Bokkel Huinink, Doranne Thomassen, Ewout W Steyerberg

|Jan 10, 2023
Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study.

Wei-Chen Lin, Wei-Chen Tai, Chung-Hsin Chang

|May 23, 2020
Impact of direct-acting antiviral therapy for hepatitis C-related hepatocellular carcinoma.

Wei-Chen Lin, Yang-Sheng Lin, Chen-Wang Chang

|Dec 07, 2017
Challenges in the diagnosis of ulcerative colitis with concomitant bacterial infections and chronic infectious colitis.

Wei-Chen Lin, Chen-Wang Chang, Ming-Jen Chen

Pageof 2

Frequent Collaborators

2 joint publications

Shu-Chen Wei

1 joint publications

Sebastiaan Ten Bokkel Huinink

1 joint publications

Aurelien Amiot

1 joint publications

Pauline Rivière